Skip to main content

Can Blood Pressure Medication Help with COPD?



The American Lung Association's Airways Clinical Research Centers (ACRC) and the National Heart, Lung, and Blood Institute Pulmonary Trials are teaming up to conduct a study to see if a common blood pressure medication can help patients with chronic obstructive pulmonary disease (COPD), a disease that includes emphysema and chronic bronchitis. The study, Losartan Effects on Emphysema Progression (LEEP) Clinical Trial, expands on research conducted by the ACRC. We talked with Robert Wise, M.D., who is the principal investigator along with Janet Holbrook, M.D., from Johns Hopkins University to learn about the trial and its potential benefits for patients living with COPD.

Q: What is COPD?
A: COPD, chronic obstructive pulmonary disease, is a lung disease that makes it difficult to breathe. With COPD, the airways in your lungs become inflamed and thicken, and the tissue where oxygen is exchanged is destroyed. The flow of air in and out of your lungs decreases, and when that happens, less oxygen gets into your body tissues, which overinflates your lungs and makes it harder to get rid of the waste gas, carbon dioxide.

Q: What is Losartan?

A: Losartan is an approved drug commonly used to treat high blood pressure and congestive heart failure.

Q: What is the LEEP Clinical Trial?
A: The LEEP Clinical Trial is based on work by Enid Neptune, M.D., of Johns Hopkins University who investigated Losartan as a potential treatment for the Marfan syndrome (a genetic disorder that affects the body's connective tissue) and discovered that Losartan prevented lung damage caused by cigarette smoke. The LEEP Clinical Trial will expand on that research through the ACRC and test patients living with COPD and emphysema to find if Losartan has any effect on the disease progression.

Q: What's important about this trial?
A: Currently, people with COPD use inhalers and oral steroids to treat symptoms and prevent them from worsening. There is no go-to therapy, however, that actually halts or slows the ongoing damage. This trial will investigate whether or not Losartan will be effective in changing the natural history of COPD.

Q: What's different about the ACRC's approach to this trial?
A: In the past, evaluation of treatments that reduce emphysema progress have been limited because they require a large number of participants and extended follow-up to establish whether or not the proposed treatment was effective on lung function or mortality. As the nation's largest not-for-profit network of clinical research centers dedicated to COPD and asthma, the ACRC can leverage its network of 17 clinical research centers and 24 trial sites to recruit large numbers of patients, as well as make it possible for patients from across the country in many demographic groups to participate in the LEEP Clinical Trial.

Q: What's required of the trial's participants?
A: The LEEP Clinical Trial will run for a year. Participants will take a lung health test and receive a high-resolution CT scan to determine the amount of lung damage they have at the start of the trial. During the trial, they will take one pill daily. At the end of their participation, each patient will have a CT scan to observe whether there are any changes in their lungs.

For more information about the ACRC or the LEEP, Clinical Trial visit Lung.org/clinical-trials.
More Information about COPD: https://goo.gl/VMGjwN

Comments

  1. I started on COPD Herbal treatment from Ultimate Health Home, the treatment worked incredibly for my lungs condition. I used the herbal treatment for almost 4 months, it reversed my COPD. My severe shortness of breath, dry cough, chest tightness gradually disappeared. Reach Ultimate Health Home via their email at ultimatehealthhome@gmail.com . I can breath much better and It feels comfortable!

    ReplyDelete

Post a Comment

Popular posts from this blog

POPCORN LUNGS!

Disease Name:   bronchiolitis obliterans Nickname: POPCORN LUNGS What happens inside a lung?? Breath In  Breath In---> Diaphragm contracts and moves downwards---> Lung Space increases As the Lung space increases, air is sucked from the nose and then air travels down your windpipe and into your lungs. After passing through your bronchial tubes, the air finally reaches and enters the alveoli (air sacs) Through the very thin walls of the alveoli, oxygen from the air passes to the surrounding capillaries (blood vessels). A red blood cell protein called hemoglobin helps move oxygen from the air sacs to the blood. At the same time, carbon dioxide moves from the capillaries into the air sacs. The gas has traveled in the bloodstream from the right side of the heart through the pulmonary artery. Oxygen-rich blood from the lungs is carried through a network of capillaries to the pulmonary vein. This vein delivers the oxygen-rich blood to the left side of the hea...

Difference Between COPD, Asthma, Emphysema and Bronchitis

Chronic obstructive pulmonary disease (COPD) is a chronic disease composed of multiple components, which can include asthma, emphysema and/or chronic bronchitis. To reach a diagnosis of COPD you must have two or more of these diseases as diagnosed by your pulmonary (lung) doctor. All of these are considered to be obstructive respiratory diseases. Obstructive lung diseases are categorized as such because they impair the ability of your body to breathe oxygen into the lungs and expire carbon dioxide out of the lungs. Since COPD is a combination of two or more diseases, your symptoms tend to be more severe than if you suffered from only one of the diseases. Various Stages of Chronic Obstructive Pulmonary Disease(COPD) STAGE 1 - Mild COPD STAGE 2 - Moderate COPD STAGE 3 - Severe COPD STAGE 4 - Very Severe COPD STAGE-1: Chronic Obstructive Pulmonary Disease (COPD) is a scourge in numerous parts of the world. Most patients with COPD exhibit gentle ailment. Mil...

Risk Factors and Prevention of Chronic Lung Diseases

When you think of chronic lung disease, you may think of lung cancer, but there are actually many different types. Altogether, lung diseases accounted for more than 3 million people die each year from COPD and 235 million people suffer from asthma, a common disease among children according to the World Health Organization . These types of lung diseases may affect your airways, lung tissues, or circulation of blood in and out of your lungs. Here are the most common types, their causes and risk factors, and potential symptoms that may signal the need for medical attention. Asthma Asthma is one of the most common types of chronic lung disease. When triggered, your lungs become swollen and narrow, making it harder to breathe. Symptoms include: Wheezing Being unable to take in enough air Coughing Feeling tightness in your chest If you experience these symptoms, it’s important to see a doctor right away. Triggers may include allergens, dust, pollution, stress...